$COR Cashflow Statement | Understand Stock

$COR

$325.37 -$4.63 (1.4%) Close

$COR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Sep 30, 2025	FY2024 12 months to Sep 30, 2024	FY2023 12 months to Sep 30, 2023	FY2022 12 months to Sep 30, 2022	FY2021 12 months to Sep 30, 2021
OPERATING ACTIVITIES
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, including amounts charged to cost of goods sold
Amortization, including amounts charged to interest expense
Provision for credit losses
Provision (benefit) for deferred income taxes
Share-based compensation expense
LIFO (credit) expense
Impairment of assets, including goodwill
Gain on sale of equity investment
Loss (gain) on divestiture of businesses
Loss on early retirement of debt
Turkey highly inflationary impact
Adjustments
Equity units
Predefined business objective
(Gain) loss on remeasurement of equity investment
Gain on divestiture of equity investment
Other, net
Changes in operating assets and liabilities, excluding the effects of acquisitions and divestitures:
Accounts receivable
Inventories
Income tax receivable
Prepaid expenses and other assets
Accounts payable
Income taxes payable
Accrued expenses
Other liabilities
Income taxes payable and other liabilities
Long-term accrued litigation liability

NET CASH PROVIDED BY OPERATING ACTIVITIES
INVESTING ACTIVITIES
Capital expenditures
Cost of acquired companies, net of cash acquired
Cost of equity investments
Proceeds from sale of property and equipment
Non-customer note receivable
Proceeds from divestiture of businesses
Other, net
NET CASH USED IN INVESTING ACTIVITIES

FINANCING ACTIVITIES
Senior notes and loan borrowings
Senior notes and loan repayments
Borrowings under revolving and securitization credit facilities
Repayments under revolving and securitization credit facilities
Payment of premium on early retirement of debt
Purchases of common stock
Exercises of stock options
Cash dividends on common stock
Profarma retail equity offering
Employee tax withholdings related to restricted share vesting
Other, net
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS, AND RESTRICTED CASH
INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH, INCLUDING CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE
LESS: INCREASE IN CASH CLASSIFIED WITHIN ASSETS HELD FOR SALE
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
Cash, cash equivalents, and restricted cash at beginning of year
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH AT END OF YEAR

Comments